JP Morgan Reiterates Overweight Rating on Kodiak Sciences Inc. (KOD)

Market Context

Kodiak Sciences Inc. operates in the Healthcare sector. The stock currently trades at $39.83 with a market capitalization of $1.3B. The stock has gained 469.6% over the past 52 weeks.

Analyst coverage from JP Morgan provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Kodiak Sciences Inc..

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Kodiak Sciences Inc.

Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Aug 03, 2026	JP Morgan	Overweight	N/A
May 11, 2026	Chardan Capital	Buy	N/A
Mar 27, 2026	UBS	Buy	N/A
Mar 27, 2026	HC Wainwright & Co.	Buy	N/A
Feb 10, 2026	HC Wainwright & Co.	Buy	N/A

Related Tools: Analyst Ratings Dashboard | View KOD Stock Page